 
May 20, 2025, 10 a.m. - noon
As part of the Trump Administration’s commitment to transform American health care and rebuild trust in public health, the U.S. Food and Drug Administration’s Commissioner Martin A. Makary, M.D., M.P.H., will lead a roundtable discussion of an independent panel of scientific experts to discuss the safety and necessity of talc as an additive in food, drug, and cosmetic products. This public roundtable, taking place on Tuesday, May 20, 2025, at 10 a.m. ET, will follow a transparent process grounded in gold standard science, setting precedents for future discussions.
The expert panel discussion will take place at the FDA’s White Oak Campus in Silver Spring, Maryland. The public and members of the media may attend the event. The session will be livestreamed.
Space is limited. Registration is required for in-person attendance. Please use the link below to register and plan to arrive at least 30 minutes prior to the start time to be checked in.
Please use the link below to view via livestream.
Link to Press Release below.
About Us
The Public Engagement Staff resides within the Office of the Commissioner and falls under the Office of External Affairs. We aim to build stronger relationships with external parties in order to better inform our policy making process, identify policy hurdles or misconceptions, and create strategic collaborations. For more information, please contact us at PublicEngagement@fda.hhs.gov. For patient specific inquiries, please contact us at Patients Ask FDA.
|
